Tag Archives: Specialization

Pharma deal frenzy points to fundamental change in strategy

Posted on April 23, 2014 by Alexander Szewczak

Pharmaceutical giants Novartis and GSK announced a large swap in business units on Tuesday, resulting in both companies becoming significantly more specialized — reversing their decades-long traditional strategies of greater diversification across product lines. The Wall Street Journal has more than … Continue reading →

Posted in Pharmaceutical Industry | Tagged , , , , , | 1 Comment